SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and ...
- Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled in Late April-
Bruce Mackle Angelos Stergiou Steering Committee Genfleet Therapeutics Shanghai Inc Lifesci Advisors Steering Committee Guided Interim Analysis Imminent
Source: eagletribune.com